Atezolizumab Monotherapy for Patients With Metastatic Urothelial Cancer
Interview with Daniel P. Petrylak, MD, PhD, author of Atezolizumab (MPDL3280A) Monotherapy for Patients With Metastatic Urothelial Cancer: Long-term Outcomes From a Phase 1 Study
